• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于竞争性内源性RNA网络鉴定肺腺癌中的关键基因

Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.

作者信息

Song Zikun, Zhang Yinjiang, Chen Zheren, Zhang Bicheng

机构信息

Department of Intensive Care Medicine, The People's Second Hospital of Liaocheng, Linqing, Shandong 252601, P.R. China.

School of Pharmacy, Minzu University of China, Beijing 100081, P.R. China.

出版信息

Oncol Lett. 2021 Jan;21(1):60. doi: 10.3892/ol.2020.12322. Epub 2020 Nov 19.

DOI:10.3892/ol.2020.12322
PMID:33281971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709547/
Abstract

Lung adenocarcinoma (LUAD) is the most commonly diagnosed type of lung cancer and exhibits a high morbidity. The present study aimed to investigate the long non-coding RNA (lncRNA)-associated competing endogenous RNA (ceRNA) mechanisms in LUAD. The receptor activity modifying protein 2-antisense RNA 1 (RAMP2-AS1) was identified using GSE113852 and GSE130779 datasets downloaded from the Gene Expression Omnibus database, and the downregulation of RAMP2-AS1 was the most significant in LUAD. In addition, microRNA (miR)-296-5p was identified to bind to RAMP2-AS1 via bioinformatics analysis. Subsequently, CD44, cyclin D3 (CCND3), neurocalcin δ (NCALD), microtubule actin crosslinking factor 1 (MACF1) and potassium channel tetramerization domain containing 15 were obtained by intersecting the predicted target genes of miR-296-5p and 368 differentially expressed mRNAs in LUAD. According to the Gene Expression Profiling Interactive Analysis and UALCAN databases, these five mRNAs were downregulated in LUAD, and their expression levels were positively correlated with those of RAMP2-AS1. CD44, CCND3, NCALD and MACF1 were selected as key mRNAs in LUAD based on prognostic analyses. Furthermore, functional enrichment analyses were performed and an interaction network was constructed to reveal the functions of the RAMP2-AS1-associated ceRNA in LUAD. The results indicated that the functions were mainly enriched in generic transcription pathways, cyclin D-associated events in G and epithelial stromal transformation. Reverse transcription-quantitative PCR assays revealed that RAMP2-AS1, CD44, CCND3, NCALD and MACF1 expression was lower in tumor tissues than in normal tissues, while miR-296-5p expression was higher in tumor tissues compared with in normal tissues. The association between RAMP2-AS1 and MACF1 was further confirmed using experiments. Overall, the present results indicated that RAMP2-AS1, miR-296-5p, CD44, CCND3, NCALD and MACF1 may be involved in LUAD progression and may therefore serve as potential biomarkers and provide a theoretical basis for the study of the pathogenesis of LUAD.

摘要

肺腺癌(LUAD)是最常被诊断出的肺癌类型,发病率很高。本研究旨在探讨LUAD中长链非编码RNA(lncRNA)相关的竞争性内源RNA(ceRNA)机制。利用从基因表达综合数据库下载的GSE113852和GSE130779数据集鉴定出受体活性修饰蛋白2反义RNA1(RAMP2-AS1),且RAMP2-AS1的下调在LUAD中最为显著。此外,通过生物信息学分析鉴定出微小RNA(miR)-296-5p与RAMP2-AS1结合。随后,通过将miR-296-5p的预测靶基因与LUAD中368个差异表达的mRNA进行交叉分析,获得了CD44、细胞周期蛋白D3(CCND3)、神经钙蛋白δ(NCALD)、微管肌动蛋白交联因子1(MACF1)和含钾通道四聚化结构域15。根据基因表达谱交互式分析和UALCAN数据库,这5种mRNA在LUAD中表达下调,且它们的表达水平与RAMP2-AS1的表达水平呈正相关。基于预后分析,选择CD44、CCND3、NCALD和MACF1作为LUAD中的关键mRNA。此外,进行了功能富集分析并构建了相互作用网络,以揭示LUAD中RAMP2-AS1相关ceRNA的功能。结果表明,这些功能主要富集在通用转录途径、G期细胞周期蛋白D相关事件和上皮间质转化中。逆转录定量PCR分析显示,肿瘤组织中RAMP2-AS1、CD44、CCND3、NCALD和MACF1的表达低于正常组织,而miR-296-5p在肿瘤组织中的表达高于正常组织。通过实验进一步证实了RAMP2-AS1与MACF1之间的关联。总体而言,目前的结果表明,RAMP2-AS1、miR-296-5p、CD44、CCND3、NCALD和MACF1可能参与LUAD的进展,因此可能作为潜在的生物标志物,并为LUAD发病机制的研究提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/6ad2cc02ce4d/ol-21-01-12322-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/995d6da34fa5/ol-21-01-12322-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/d03799e7cb32/ol-21-01-12322-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/0afd6492c02e/ol-21-01-12322-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/538529f014c4/ol-21-01-12322-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/828c7ef7eef1/ol-21-01-12322-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/f9b6ba9290ea/ol-21-01-12322-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/2edf9b9b7681/ol-21-01-12322-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/356c63526904/ol-21-01-12322-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/6ad2cc02ce4d/ol-21-01-12322-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/995d6da34fa5/ol-21-01-12322-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/d03799e7cb32/ol-21-01-12322-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/0afd6492c02e/ol-21-01-12322-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/538529f014c4/ol-21-01-12322-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/828c7ef7eef1/ol-21-01-12322-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/f9b6ba9290ea/ol-21-01-12322-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/2edf9b9b7681/ol-21-01-12322-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/356c63526904/ol-21-01-12322-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ef/7709547/6ad2cc02ce4d/ol-21-01-12322-g08.jpg

相似文献

1
Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.基于竞争性内源性RNA网络鉴定肺腺癌中的关键基因
Oncol Lett. 2021 Jan;21(1):60. doi: 10.3892/ol.2020.12322. Epub 2020 Nov 19.
2
LncRNA TGFB2-AS1 regulates lung adenocarcinoma progression via act as a sponge for miR-340-5p to target EDNRB expression.长链非编码RNA TGFB2-AS1通过作为miR-340-5p的海绵来靶向EDNRB表达,从而调节肺腺癌进展。
Am J Transl Res. 2020 Jul 15;12(7):3813-3821. eCollection 2020.
3
Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.下调lncRNA NUTM2A-AS1通过调节miR-590-5p/METTL3轴抑制肺腺癌细胞活力。
Oncol Lett. 2021 Nov;22(5):798. doi: 10.3892/ol.2021.13059. Epub 2021 Sep 20.
4
Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.通过综合生物信息学分析鉴定与肺腺癌化疗耐药相关的竞争性内源性 RNA 轴“SVIL-AS1/miR-103a/ICE1”。
Cancer Med. 2021 Sep;10(17):6022-6034. doi: 10.1002/cam4.4132. Epub 2021 Jul 15.
5
lncRNA CERS6-AS1 upregulates the expression of ANLN by sponging miR-424-5p to promote the progression and drug resistance of lung adenocarcinoma.长链非编码RNA CERS6-AS1通过海绵吸附miR-424-5p上调ANLN的表达,从而促进肺腺癌的进展和耐药性。
Noncoding RNA Res. 2023 Dec 1;9(1):221-235. doi: 10.1016/j.ncrna.2023.11.013. eCollection 2024 Mar.
6
LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.长链非编码 RNA MAFG-AS1 通过调控 miR-744-5p/MAFG 轴促进肺腺癌细胞的增殖。
Eur J Pharmacol. 2019 Sep 15;859:172465. doi: 10.1016/j.ejphar.2019.172465. Epub 2019 Jun 15.
7
FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.FAM83A和FAM83A-AS1在肺腺癌中均发挥致癌作用。
Oncol Lett. 2021 Apr;21(4):297. doi: 10.3892/ol.2021.12558. Epub 2021 Feb 17.
8
Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.微小RNA-198-5p下调在肺腺癌中的临床价值及其潜在途径
Oncol Lett. 2019 Sep;18(3):2939-2954. doi: 10.3892/ol.2019.10610. Epub 2019 Jul 12.
9
lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p/VMA21 axis in lung adenocarcinoma.长链非编码 RNA ZFPM2-AS1 通过 miR-18b-5p/VMA21 轴促进肺腺癌增殖。
J Cell Biochem. 2020 Jan;121(1):313-321. doi: 10.1002/jcb.29176. Epub 2019 Jul 11.
10
LncRNA ST7-AS1, by regulating miR-181b-5p/KPNA4 axis, promotes the malignancy of lung adenocarcinoma.长链非编码RNA ST7-AS1通过调控miR-181b-5p/KPNA4轴促进肺腺癌的恶性进展。
Cancer Cell Int. 2020 Dec 17;20(1):568. doi: 10.1186/s12935-020-01652-7.

引用本文的文献

1
A Multifaceted Giant Protein Microtubule-Actin Cross-Linking Factor 1.一种多面巨型蛋白质微管-肌动蛋白交联因子1
Int J Mol Sci. 2025 Mar 30;26(7):3204. doi: 10.3390/ijms26073204.
2
Serum lncRNA RAMP2-AS1 Served as a Biomarker of Deep Vein Thrombosis Occurrence and Development in Elderly.血清长链非编码RNA RAMP2-AS1作为老年人深静脉血栓形成和发展的生物标志物。
Indian J Hematol Blood Transfus. 2024 Oct;40(4):660-667. doi: 10.1007/s12288-024-01782-2. Epub 2024 May 6.
3
Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.

本文引用的文献

1
Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas.胰腺导管腺癌中淋巴结大小及其与淋巴结转移的关系。
J Pathol Transl Med. 2020 Sep;54(5):387-395. doi: 10.4132/jptm.2020.06.23. Epub 2020 Jul 21.
2
Genomic characterization of vulvar squamous cell carcinoma.外阴鳞状细胞癌的基因组特征分析。
Gynecol Oncol. 2020 Sep;158(3):547-554. doi: 10.1016/j.ygyno.2020.06.482. Epub 2020 Jun 24.
3
Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.
长链非编码 RNA MIDEAS-AS1 通过转录激活 NCALD 抑制三阴性乳腺癌的生长和转移。
Breast Cancer Res. 2023 Sep 28;25(1):109. doi: 10.1186/s13058-023-01709-1.
4
A hybrid deep forest-based method for predicting synergistic drug combinations.基于混合深度森林的协同药物组合预测方法。
Cell Rep Methods. 2023 Feb 21;3(2):100411. doi: 10.1016/j.crmeth.2023.100411. eCollection 2023 Feb 27.
5
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.阐明 G 蛋白偶联受体和受体活性修饰蛋白的相互作用组。
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
6
Prognostic significance of AP-2α/γ targets as cancer therapeutics.AP-2α/γ 靶标作为癌症治疗药物的预后意义。
Sci Rep. 2022 Mar 31;12(1):5497. doi: 10.1038/s41598-022-09494-1.
抑制光谱plakin蛋白微管肌动蛋白交联因子1可使胶质母细胞瘤对放疗敏感。
Brain Tumor Res Treat. 2020 Apr;8(1):43-52. doi: 10.14791/btrt.2020.8.e1.
4
Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis.源自软骨肉瘤细胞的外泌体长链非编码RNA RAMP2-AS1通过miR-2355-5p/VEGFR2轴促进血管生成。
Onco Targets Ther. 2020 Apr 20;13:3291-3301. doi: 10.2147/OTT.S244652. eCollection 2020.
5
Identification of new genes of pleomorphic adenoma.多形性腺瘤新基因的鉴定
Medicine (Baltimore). 2019 Dec;98(51):e18468. doi: 10.1097/MD.0000000000018468.
6
Expression Profile and Potential Functions of Circulating Long Noncoding RNAs in Acute Ischemic Stroke in the Southern Chinese Han Population.中国南方汉族人群急性缺血性卒中患者循环长链非编码RNA的表达谱及潜在功能
Front Mol Neurosci. 2019 Nov 29;12:290. doi: 10.3389/fnmol.2019.00290. eCollection 2019.
7
LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells.长链非编码RNA NEAT1通过调控miR-296-5p/CNN2轴促进肝癌细胞的增殖、迁移和侵袭。
Onco Targets Ther. 2019 Nov 18;12:9887-9897. doi: 10.2147/OTT.S228917. eCollection 2019.
8
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2.KCTD15通过提高肿瘤抑制因子KCASH2的蛋白质水平来抑制髓母细胞瘤细胞中的Hedgehog信号通路。
Oncogenesis. 2019 Nov 4;8(11):64. doi: 10.1038/s41389-019-0175-6.
9
Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.长链非编码 RNA FOXD3-AS1 的抑制作用通过上调 miR-296-5p 并抑制 TGF-β1/Smads 信号通路抑制甲状腺癌细胞的侵袭和迁移。
Mol Cell Endocrinol. 2020 Jan 15;500:110634. doi: 10.1016/j.mce.2019.110634. Epub 2019 Oct 31.
10
EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells.表皮生长因子受体(EGFR)特异性酪氨酸激酶抑制剂修饰自然杀伤(NK)细胞介导的抗肿瘤活性,以对抗卵巢癌细胞。
Int J Mol Sci. 2019 Sep 22;20(19):4693. doi: 10.3390/ijms20194693.